BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35862070)

  • 41. Associations of Flavored e-Cigarette Uptake With Subsequent Smoking Initiation and Cessation.
    Friedman AS; Xu S
    JAMA Netw Open; 2020 Jun; 3(6):e203826. PubMed ID: 32501490
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characteristics of nicotine vaping products used by participants in the 2016 ITC Four Country Smoking and Vaping Survey.
    O'Connor RJ; Fix BV; McNeill A; Goniewicz ML; Bansal-Travers M; Heckman BW; Cummings KM; Hitchman S; Borland R; Hammond D; Levy D; Gravely S; Fong GT
    Addiction; 2019 Oct; 114 Suppl 1(Suppl 1):15-23. PubMed ID: 30701622
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cannabis, Vaping, and Respiratory Symptoms in a Probability Sample of U.S. Youth.
    Boyd CJ; McCabe SE; Evans-Polce RJ; Veliz PT
    J Adolesc Health; 2021 Jul; 69(1):149-152. PubMed ID: 33676824
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Associations of Electronic Cigarette Nicotine Concentration With Subsequent Cigarette Smoking and Vaping Levels in Adolescents.
    Goldenson NI; Leventhal AM; Stone MD; McConnell RS; Barrington-Trimis JL
    JAMA Pediatr; 2017 Dec; 171(12):1192-1199. PubMed ID: 29059261
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adolescents' Use of Basic, Intermediate, and Advanced Device Types for Vaping.
    Pepper JK; MacMonegle AJ; Nonnemaker JM
    Nicotine Tob Res; 2019 Jan; 21(1):55-62. PubMed ID: 29294122
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cigarettes, E-cigarettes, and Adolescents' Oral Health: Findings from the Population Assessment of Tobacco and Health (PATH) Study.
    Akinkugbe AA
    JDR Clin Trans Res; 2019 Jul; 4(3):276-283. PubMed ID: 30931714
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Patterns of Non-Cigarette Tobacco and Nicotine Use Among Current Cigarette Smokers and Recent Quitters: Findings From the 2020 ITC Four Country Smoking and Vaping Survey.
    Li L; Borland R; Cummings KM; Gravely S; Quah ACK; Fong GT; Miller CR; Goniewicz ML; Le Grande M; McNeill A
    Nicotine Tob Res; 2021 Aug; 23(9):1611-1616. PubMed ID: 33693833
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased nicotine vaping due to the COVID-19 pandemic among US young adults: Associations with nicotine dependence, vaping frequency, and reasons for use.
    Parks MJ; Fleischer NL; Patrick ME
    Prev Med; 2022 Jun; 159():107059. PubMed ID: 35460719
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence of disposable pod use and consumer preference for e-cigarette product characteristics among vape shop customers in Southern California: a cross-sectional study.
    Galimov A; Leventhal A; Meza L; Unger JB; Huh J; Baezconde-Garbanati L; Sussman SY
    BMJ Open; 2021 Oct; 11(10):e049604. PubMed ID: 34610937
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Protective Factors for Nicotine and Marijuana Vaping Among U.S. Adolescents.
    Parks MJ; Patrick ME
    Am J Prev Med; 2022 Mar; 62(3):414-421. PubMed ID: 34924259
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modes of delivery in concurrent nicotine and cannabis use ("co-use") among youth: Findings from the International Tobacco Control (ITC) Survey.
    Smith DM; Miller C; O'Connor RJ; Kozlowski LT; Wadsworth E; Fix BV; Collins RL; Wei B; Goniewicz ML; Hyland AJ; Hammond D
    Subst Abus; 2021; 42(3):339-347. PubMed ID: 31951806
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Associations Between Family and Peer E-Cigarette Use With Adolescent Tobacco and Marijuana Usage: A Longitudinal Path Analytic Approach.
    Coleman M; Donaldson CD; Crano WD; Pike JR; Stacy AW
    Nicotine Tob Res; 2021 May; 23(5):849-855. PubMed ID: 33038257
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence trends and factors associated with vaping in Ontario (2015 to 2018) and Quebec (2017 to 2019), Canada.
    Czoli CD; Luongo G; Mischki T
    Health Rep; 2022 Jul; 33(7):13-23. PubMed ID: 35862069
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vape Factor Fast Find-Adult (VF3-A): a prototype survey method for recording brand-specific vaping factors in adult populations.
    Ross CS; Zhang TC; DeJong W; Siegel M
    Tob Control; 2019 Jan; 28(1):20-26. PubMed ID: 29572355
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of smoking prevalence in Canada before and after nicotine vaping product access using the SimSmoke model.
    Levy DT; Cadham CJ; Yuan Z; Li Y; Gravely S; Cummings KM
    Can J Public Health; 2023 Dec; 114(6):992-1005. PubMed ID: 37540451
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Changes from 2017 to 2018 in e-cigarette use and in ever marijuana use with e-cigarettes among US adolescents: analysis of the National Youth Tobacco Survey.
    Farsalinos K; Barbouni A; Niaura R
    Addiction; 2021 Jan; 116(1):139-149. PubMed ID: 32533631
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Exploring Differences in Daily Vaping of Nicotine and Cannabis among People Who Use Drugs in New Zealand.
    Rychert M; Romeo JS; Wilkins C
    Subst Use Misuse; 2023; 58(11):1388-1398. PubMed ID: 37328432
    [No Abstract]   [Full Text] [Related]  

  • 58. A qualitative study of e-cigarette emergence and the potential for renormalisation of smoking in UK youth.
    Brown R; Bauld L; de Lacy E; Hallingberg B; Maynard O; McKell J; Moore L; Moore G
    Int J Drug Policy; 2020 Jan; 75():102598. PubMed ID: 31785547
    [TBL] [Abstract][Full Text] [Related]  

  • 59. E-Cigarette-Only and Dual Use among Adolescents in Ireland: Emerging Behaviours with Different Risk Profiles.
    Bowe AK; Doyle F; Stanistreet D; O'Connell E; Durcan M; Major E; O'Donovan D; Kavanagh P
    Int J Environ Res Public Health; 2021 Jan; 18(1):. PubMed ID: 33466304
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Responses to potential nicotine vaping product flavor restrictions among regular vapers using non-tobacco flavors: Findings from the 2020 ITC Smoking and Vaping Survey in Canada, England and the United States.
    Gravely S; Smith DM; Liber AC; Cummings KM; East KA; Hammond D; Hyland A; O'Connor RJ; Kasza KA; Quah ACK; Loewen R; Martin N; Meng G; Ouimet J; Thompson ME; Boudreau C; McNeill A; Sweanor DT; Fong GT
    Addict Behav; 2022 Feb; 125():107152. PubMed ID: 34695685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.